Shopping Cart
Remove All
Your shopping cart is currently empty
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $35 | - | In Stock | |
| 10 mg | $56 | - | In Stock | |
| 25 mg | $94 | - | In Stock | |
| 50 mg | $151 | - | In Stock | |
| 100 mg | $228 | - | In Stock | |
| 200 mg | $342 | - | In Stock |
| Description | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
| Synonyms | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid |
| Molecular Weight | 281.33 |
| Formula | C13H15NO4S |
| Cas No. | 1695562-36-7 |
| Smiles | C(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (195.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.